GRI Bio(GRI)
$1.82-0.01 (-0.55%)
GRI
GRI Bio financials statements
$1.82
At close:-0.01 (-0.55%)
Want to see GRI full AI Analyst Report?
GRI Bio (GRI) Income Statement
369 Followers
GRI Bio Income Statement
Last quarter (Q2 2026), GRI Bio's total revenue was $0.00. In Q2, GRI Bio's net income was $-1.64M. See GRI Bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -4.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 11.98M | $ 8.23M | $ 11.39M | $ 2.24M | $ 1.06M | |
| Depreciation and Amortization | $ 4.00K | $ 4.00K | $ 4.00K | $ 3.00K | $ 73.00K |
| $ -11.97M | $ -8.23M | $ -10.95M | $ -2.56M | $ -989.00K | |
| $ -11.98M | $ -8.23M | $ -11.39M | $ -2.24M | $ -1.06M | |
| $ 21.00K | $ 28.00K | $ -1.65M | $ -978.00K | $ -497.00K | |
| $ -11.96M | $ -8.21M | $ -13.04M | $ -3.22M | $ -1.56M | |
| $ -11.96M | $ -8.21M | $ -13.04M | $ -3.22M | $ -1.56M | |
| Per Share Metrics | |||||
| Basic EPS | $ -121.80 | $ 0.33 | $ -140450.24 | $ -47135.48 | $ -2827.16 |
| Diluted EPS | $ -121.80 | $ 0.33 | $ -140450.24 | $ -47135.48 | $ -2827.16 |
| Weighted Average Shares Outstanding | 98.16K | 4.90M | 1.58K | 1.16K | 11.60K |
| Weighted Average Shares Outstanding (Diluted) | 98.16K | 4.92M | 1.58K | 1.16K | 11.60K |
Currency in USD
